Series C
The San Francisco-based telemental health company will use funds to grow into new markets.
An R&D cloud platform which supports scientists to share and access progress with the development of biopharmaceutical therapeutics has raised $35 million in investment capital.
Funding will be used to push for regulatory approval of its flagship synthetic implant product.